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ABSTRACT
Background: The folate metabolism is a pathway that may involve in the non-syndromic
Autism Spectrum Disorder (ASD). Methylenetetrahydrofolate reductase enzyme has a key
role in folate metabolism. The C677T polymorphism of MTHFR gene could reduce the
effectiveness of the enzyme.
Objectives: To evaluate the frequency of MTHFR geneC677T polymorphism for non-
syndromic ASD patients.
Method: Thirty-four DNA samples were taken from each group. PCR mixture was consisted
of 1µL DNA, 2.5µL PCR buffer, 0.5µL dNTP, 1.5µL MgCL2, 0.125µLTaqenzyme,
0.5µLofforwardandreverseprimerandaquabidesttoreach a volume of 25 µL. The PCR profiles
were initiation 95ºC for 5 min, denaturation 94ºC for 1min, annealing 55ºCfor 45 seconds, and
elongation 72ºC for30 seconds. The cycles were done in 35 times an dfinal elongation was at
72ºC for 5min. The PCR product was 198bp, and then digested by the Hinfl enzyme for
16hours at 37°C, and visualized using 2% agarose gel and then electrophoresed for 30 minutes
at 100 volts.
Result: Non-syndromic ASD samples showed none had homozygote mutant type (677TT), 3
(8.8%) samples had heterozygote (677CT)and 31 (91.2%) samples had wild type (677CC).
Meanwhile, normal control showed only 1 (2.9%)sample had homozygote mutant
type(677TT), 9 (26.5%) samples had heterozygote (677CT)and 24 (70.6%) samples had  wild
type (677CC).
Conclusion: The frequency ofMTHFRgeneC677T polymorphism in patients with non-
syndromic ASD and controls are not significantly different.
Keywords: ASD, MTHFR C677T, polymorphism
INTRODUCTION
Autism Spectrum Disorder (ASD) is group of neuro
developmental disorders ranging from pervasive
developmental disorders apart from attention deficit
hyperactivity disorders and attention deficit disorders to
autistic disorders.1 Clinical, neuroimaging, neuropathology,
and neurochemical examination show that ASD is a neuro-
cortical system disorders that causedby disruption of
information processing in the nervous system.
This may occur from the synaptic and dendritic
process for connectivity to the brain structure, and seems
to be influenced by genetic and environmental factors. 1
Some risk factors may influence the gene-gene and
gene-environment interactions.2 These interactions can
either be a toxic environmental factor or epigenetic factor,
which may alter the gene functions, and in turn alters the
neural network.
Journal of Biomedicine and Translational Research 02 (2015) 7 -12
8
Specific examples of epigenetic factor may be derived
from physical aspect (i.e. active biochemical substance) or
psychological aspect (i.e. stress) that may influence the
chemical composition of the brain, genes that became
active/passive at the time of development, or changes in
gene expression.2
Methylenetetrahydrofolate reductase (MTHFR) enzyme
plays an important role in the chemical reaction for the
synthesis of folic acid. This enzyme acts as a catalyst in the
transformation of 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate.(Ref) 5-methyltetrahydrofolate is a
form of folate found in the main circulation and used in the
remethylation of homocyste into methionine.3 The folate-
methionine reaction pathway plays a role in DNA synthesis,
DNA methylation, and cellular oxidation-reduction
balance.4-6 Methionine is an amino acid that plays an
important role in protein synthesis, because it serves as a
start codon for protein synthesis. Impaired folate-
methionine reaction pathway have been identified in
individuals with ASD.7 The reduction of cell proliferation
ability to regenerate in the critical region of the brain was
caused by the lost of nucleotide synthesis.8,9 Currently, the
screening for MTHFR gene is routinely performed among
ASD because it has been well established that folate and
methylation may influence the development of neural
networks.10
MTHFR gene is located in the short arm of chromosome
1 at 1p36.3, and has 9 exons. Some common
polymorphisms in MTHFR gene are A1298C (rs1801131)
on exon 7 and C677T (rs1801133) on exon 4, both of which
are known to reduce the activity of MTHFRenzyme.11
C677T polymorphism resulted in the decrease of enzyme
activity by 45% compared with the wild type.
Heterozygocity for allele C677T (677CT) and allele
A1298C (1298AC) showed biochemical characteristics
more closely resembling the homozygous 677TT.12
SUBJECT AND METHOD
This was a cross sectional study that was carried out for
three months from September 2012 to November 2012 at
Center for Biomedical Research (CEBIOR) Faculty of
Medicine Diponegoro University Semarang and at Health
Research Unit (HRU) laboratory Faculty of Medicine
Padjadjaran University Bandung. Samples was obtained
DNA from previous ASD studyat CEBIOR laboratory
Faculty of Medicine Diponegoro University Semarang and
controls was obtained from DNA from Health Research
Unit (HRU) laboratory Faculty of Medicine Padjadjaran
University. Sex and age of the control group were matched
to the non-syndromic ASDpatients. The sex ratio for male
and female patients with non-syndromic ASD was1:6.
Patient’s age was ranging from6 to 17 years old.
Laboratory procedures for the MTHFR gene C677T
polymorphism analysis were PCR (Polymerase Chain
Reaction) - RFLP (Restriction Fragment Length
Polymorphism).The materials used for the study were DNA
extracts. Reagents used for PCR mixed were consisted of
aquabidest, PCR buffer (P-2192; Sigma-Aldrich, St Louis,
MO, USA), dNTPs (Promega, Madison, WI, USA),
MgCL2, TAG enzyme (D-6677; Sigma-Aldrich) and
forward primer (5’-AGG-ACG-GTG-CGG-TGA-GAG-TG-
3’) and reverse primer (5’-TGA-AGG-AGA-AGG-TGT-
CTG-CGG-GA-3’). Hinf1enzyme (Ferment as UAB,
Vilnius, Lithuania) was used for RFLP and red buffer
(R+) (Ferment as UAB). PCR products were then
visualized using agarose gel 2%, TBE Buffer 0.5x,
Ethidium Bromide 0.5%.13 Making the PCR mixture for
one reaction or one DNA sample with total volume of
25µl consisting of 1µL DNA, 2.5µL PCR buffer, 0.5µL
dNTP, 1.5µL MgCL2, 0.125µL Taq enzyme and 0.5µL
forward and reverse primer with aquabidest to a total
volume of 25µL. PCR amplification (Applied Biosystem)
was performed using the following process: initiation at
95ºC for 5 minutes, denaturation at 94ºC for 1 minutes,
annealing at 55ºC for 45 seconds and elongation at 72ºC
for 30 seconds. The cycle was repeated 35 times. Final
elongation at 72ºC for 5 minutes. The final PCR product is
198 base pair(bp). PCR product were then digested using
restriction enzyme as follows: 30µl PCR product, 13.5µl
aqua bidest, 1.5µl Hinfl enzyme and 5µl red buffer (R+).
Incubated for 16 hours at 37°C. Next 25µl enzyme-
digested PCR products will be planted in 2% agarose gel
which were then electrophoresed at 100 volt for 30
minutes. Hinf1 enzyme will cut the GAn↓TC sequences,
so that the sample will have 2 fragments namely 175 and
23 bp identified as 677TT that is the homozygous
polymorphism on both alleles. A 198 bp sample identified
as 677CC was a wild type homozygous on both alleles,
because Hinf1 enzyme did not cut the PCR products.
Samples consisting of 198, 175 and 23 bp fragments were
identified as 677CT, or C/T heterozygous polymorphism.
Hypothesis was tested using Chi-square statistical test
on SPSS 13.0, because this study was comparing two
unpaired categorical variables using 2x2 table to compare
the 677TT/CT and wild type 677CC polymorphism
frequency characteristics, with 95% confidence interval
and statistical significance level of p<0.05. The study had
been approved by Ethical Committee Faculty of Medicine
Diponegoro University/Dr. Kariadi HospitalSemarang and
Human Research Ethic Committee Faculty of Medicine
Padjadjaran University Bandung (appendix). Patient’s
data was obtained from the medical record from the
previous study and was kept confidentially.
RESULTS
This research included 68 samples consisting of 34
non-syndromic ASD patients and 34 normal controls. The
characteristics of the non-syndromic ASD patients were: 5
female (14.7%) and 29 male (85.3%). Samples from the
normal control populations were consisted of 7 female
samples (20.6%) and 27 male samples (79.4%) (Table 1).
Age distribution for the non-syndromic ASDpatient’s
samples ranged from 6 to 17 years with an average of
11.88 years, and from 7 to 17 years with an average of
12.09 years for the normal population samples. Sex ratio
between male and female for the non-syndromic ASD
patient group was1:6. Samples for the normal control
group were selected based on the age and sex criteria of
the non-syndromic ASD patients group.
Results for 34 samples of non-syndromic ASD patients
showed no 677TT polymorphism, 3 677CT
polymorphisms (8.8%) and 31 wild type 677CC (91.2%).
Whereas the results for 34 normal population samples
showed 1 677TT polymorphism (2.9%), 9 677CT
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polymorphisms (26.5%) and 24 wild type 677CC (70.6%),
as presented on Table 2.
Analysis for 677TT, 677CT and 677CC polymorphism
showed p= 0.087 because p>0.05 it was concluded that
there was no significant difference on the frequency of
MTHFR gene C677T polymorphism between non-
syndromic ASD patients and normal control group (Table
2).
The combined value of 677TT and 677CT
polymorphisms also showed no significantly difference in
the frequency of MTHFR gene C677T polymorphism
between non-syndromic ASD patients and normal control
(p= 0.062) (see Table 3).
Samples of non-syndromic ASD. M is the marker; Bl is
the blank (internal control).Sample no 28 showed 175 bp
and 198 bp bands. Most of the results in the non-syndromic
ASD patients group were the wild type 677CC, as pictured
on samples number 21, 22, 23, 24, 25, 26, 27, 29 and 30. It
was a 198 bp band (Figure 1).
PCR results on 677TT polymorphism can be seen on
sample number 12, with a 175 bp band. The 677CT
polymorphism showed 175 bp and 198 bp bands, as
pictured on sample number 7, 9 and 10. Whereas for 677CC
or wild type, there are one 198 bp band, as pictured on
sample number 8 and 11. Control on the K column was the
PCR product with known size of 200 bp (internal control).
The marker was a 100 bp band (Figure 2).
DISCUSSION
Distribution of 677TT polymorphism on the control
group showed 1 sample (2.9%). The number of 677TT
polymorphism on normal population differ based on ethnic
and racial groups. Control group showed more 677TT and
677CT polymorphism compared to the non-syndromic ASD
patients group, as pictured on Table 2. The different results
obtained between the analysis of polymorphism and alleles
may be caused by minimum sample size resulting in bias
between the analysis of polymorphism and allele.
The minimum sample size in this study was calculated
based on the number of homozygous 677TT on the normal
control population, which was 11%, so the minimum
sample size was 34 samples. Age and sex criteria of the
normal control group were matched to the criteria for the
non-syndromic ASD patients sample in Central Java. This
study found more 677CT genotype than 677TT genotype,
either on the non-syndromic ASD patients group or normal
control group. There was also more C allele than T allele,
either on the non-syndromic ASD or control group.
Sample size for the MTHFR gene C677T polymorphism
study may affect the study results, where studies with large
sample size (more than 168 samples) and minimum sample
size (34 or 40 samples) showed different results. Sample
size will also affect the frequency of 677TT polymorphism,
where larger sample size is associated with higher
frequency of 677TT polymorphism.
This can be observed from the study by Boris et al.
(2004) who analyzed the MTHFR gene C677T and A1298C
polymorphism on 168 Caucasian children with autism and
found a significant C677T polymorphism on MTHFR gene,
23% 677TT allele on children with autism and 11% on
control (P<0.0001). The study from Liu et al. also found a
relationship between the reduction of MTHFR enzyme
activity and the risk of autism. They found 42.9% 677TT
allele on children with autism, compared with 32.3%
677TT allele on control group (P= 0.0004).This study
involved 205 families in North America who has one or
more children with autism. Both studies were done with
large sample size, and the study by Boris et al. has
analyzed two MTHFR gene polymorphisms, C677T and
A1298C. The study by Gokcen C et al. showed no
significant association between the reduction of MTHFR
enzyme activity and MTHFR gene C677T polymorphism,
but A1298C polymorphism showed significant association
with the reduction of enzyme activity.14
In 1998, Abbate et al. studied 84 patients with heart
disease and 106 normal samples in Italy, and found no
association between MTHFR gene C677T polymorphism
and heart diseases.15 In 2001, another study by Brunelli et
al. found that MTHFR gene C677T polymorphism showed
no association with the Alzheimer.16 Kostulas et al.
studied 126 patients with ischemic cerebrovascular
disease (ICVD) and 70 patients with internal carotid artery
(ICA) stenosis, and found no significant association
between MTHFR gene C677T polymorphism and ICVD
or ICA stenosis, and also no causal relationship with the
increase of homocystein levels in ICA stenosis.17The
studies by Abbate et al., Brunelli et al. or Kostulas et al.
only analyzed the MTHFR gene C677T polymorphism
without another form of polymorphism, so there was a
possibility of another polymorphism such as A1298C.
These studies were also completed by the end of the 90s
decade, while today we already found 34 polymorphisms
with 9 frequently found polymorphisms for MTHFR gene.
Gokcen et al. (2011) found different results where ADHD
was not associated with MTHFR gene C677T
polymorphism but was associated with MTHFRg ene
A1298C polymorphism.
ASD can be caused by multiple factors, such as
environment and genetic factors. Rio Garcia et al. found
that MTHFR gene C677T and A1298C polymorphism
status on a mother, and intake of folic acid and vitamin
B12 in the early period of pregnancy is essential for the
neurobiological development of a baby.18Considering that
human brain is growing rapidly in the early period of
pregnancy and the cortical and sub cortical structures was
formed at weeks 5-25 of gestation, it is necessary to
evaluate the folic acid level in the mother.
In this case we can see that the etiology of ASD, such
as the environmental and genetic factors also include the
environmental and genetic factors from the mother.
Limitations of this study are the small sample size and the
analysis was only performed on the non-syndromic ASD
patients and not on their mothers. Non-syndromic ASD
patient samples were obtained from CEBIOR laboratory
FK UNDIP Semarang, whereas the normal control
samples were obtained from UPK laboratory FK UNPAD
Bandung, so there is a high possibility of bias. Non-
syndromic ASD patient sample group did not come from
the same race or ethnicity, so is the case for the normal
control group. Although there are several studies about the
relationship between MTHFR gene polymorphism variant
and ASD, future studies should be done to find another
genetic or environmental factor that may also contribute to
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this disorders, considering the gene and gene or gene and
environment interactions on the non-syndromic ASD.
Male normal control samples with homozygous 677TT
may require counseling about the clinical effect of this
homozygous 677TT. Individual with homozygous 677TT
has higher risk for elevated plasma homocysteine levels,
which may cause heart and blood vessels disorders. This
was caused by an endothelial dysfunction. There are other
risk factors that may accelerate and exacerbate this
condition and need to be avoided such as smoking, high fat
diets and overweight. They may also need to be informed
about the possibility of cerebrovascular disorders,
psychiatric disorders and colorectal cancer. It is highly
recommended to increase folate intake from food and folate
supplements, with minimum dose of 400µg/day, taken
continuously and regularly.
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APPENDIX
Table 1. Sample characteristics
Characteristics Non-syndromic ASD
n(%)
Control
n (%)
Sex
Female
Male
5 (14.7%)
29 (85.3%)
7 (20.6%)
27 (79.4%)
Age
Mean (Std Dev) 11,88 (±2.55) 12.09 (±2.40)
Table 2. Distribution of MTHFR gene C677T polymorphism
MTHFRgene
polymorphism
Non-syndromic ASD
n %
Control
n                    %
p
677 TT 0 0 1 2.9%
p= 0.087677 CT 3 8.8% 9 26.5%
677 CC 31 91.2% 24 70.6%
Total 34 100% 34 100%
Table 3. MTHFR gene C677T polymorphism analysis
MTHFRgene
polymorphism
Non-syndromic ASD
n                     %
Control
n                    % p
677 TT/CT 3 8.8% 10 29.4%
p= 0.062
677 CC 31 91.2% 24 70.6%
Total 34 100% 34 100%
Table 4. MTHFR gene Allele C and T 677 analysis
Allele Non-syndromic ASD Normal control
p% %
Allele C 95.6% 83.8%
p=0.045Allele T 4.4% 16.2%
Total 100% 100%
Journal of Biomedicine and Translational Research 02 (2015) 7 -12
12
Figure 1.PCR-RFLP results for MTHFRC677T gene polymorphism.
Sample no 28 showed 175bp and 198bp bands. Most of the results in the non-syndromic ASDpatients group were the wild
type 677CC, as pictured on samples number 21, 22, 23, 24, 25, 26, 27, 29 and 30. It was a 198bp band
Figure 2.PCR-RFLP results of normal samples.
PCR results on 677TT polymorphism can be seen on sample number 12, with a 175 bp band. The 677CT polymorphism
showed 175 bp and 198 bp bands, as pictured on sample number 7, 9 and 10. Whereas for 677CC or wild type, there are one
198 bp band, as pictured on sample number 8 and 11. Control on the K column was the PCR product with known size of
200 bp (internal control). The marker was a 100 bp band
300pb marker-
175
M       K        7       8         9        10       11      12
-175pb
-198pb
100pb marker-
